Safety of Adeno-associated virus-based vector-mediated gene therapy-impact of vector dose

Cancer Gene Ther. 2022 Oct;29(10):1305-1306. doi: 10.1038/s41417-021-00413-6. Epub 2022 Jan 14.

Authors

Shubham Maurya^#¹, Pratiksha Sarangi^#¹, Giridhara R Jayandharan²

Affiliations

¹ Department of Biological Sciences and Bioengineering and The Mehta Family Centre for Engineering in Medicine, Indian Institute of Technology Kanpur, Kanpur, India.
² Department of Biological Sciences and Bioengineering and The Mehta Family Centre for Engineering in Medicine, Indian Institute of Technology Kanpur, Kanpur, India. jayrao@iitk.ac.in.

^# Contributed equally.

PMID: 35027711
DOI: 10.1038/s41417-021-00413-6

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Dependovirus* / genetics
Genetic Therapy* / adverse effects
Genetic Vectors / genetics
Humans